Find Academic Supervisors

Steven NahmiasView profile

Professor

• Operations Research
• Inventory Management
• Stochastic Modeling
• +3 more

Dr. Steven Nahmias is a Professor in the Information Systems & Analytics department at Santa Clara University's Leavey School of Business. He holds degrees from Queens College, Columbia University, and a Ph.D. in Operations Research from Northwestern University. His expertise lies in stochastic modeling and inventory systems, particularly perishable inventory management. He has authored/co-authored over 50 technical papers and the influential textbook 'Production and Operations Analysis,' now in its seventh edition, used globally in business and engineering programs. His roles include Department Chair (1987–1991) and Director of the Competitive Manufacturing Institute (1991–1997). He has served on faculties at Stanford, Georgia Tech, and the University of Pittsburgh. Dr. Nahmias has been recognized with the University Award for Sustained Excellence in Scholarship (1998), and named a Distinguished Fellow by INFORMS (2010, 2014). His consulting work spans legal proceedings, inventory optimization for corporations like Shaklee and Tropicana, and keynote speaking at events such as the 2015 Amazon Research Scientist Conference. His research focuses on perishable inventory models, supply chain contracts, and stochastic processes, with applications in healthcare (e.g., blood bank management) and manufacturing. His academic contributions include editorial roles for journals like Management Science and Operations Research , and pioneering work in perishable inventory theory. His textbook has been translated into Spanish, Hebrew, and Chinese, reflecting its global impact. Recent work emphasizes dynamic inventory control strategies under uncertainty, with applications to perishable goods and supply chain efficiency.

Andrew SuView profile

Professor

• Bioinformatics
• Computational Biology
• Genetics
• +5 more

Andrew Su, PhD, is a Professor in the Department of Integrative Structural and Computational Biology at Scripps Research. He holds the Elden and Verna Strahm Chair for Medical Research. His lab focuses on biomedical discovery using quantitative methods, leveraging computational tools and data mining to address challenges in genetics, cancer biology, immunology, and genomics. Su's team develops open-source platforms like BioGPS and the Gene Wiki, emphasizing community-driven knowledge sharing. Key projects include genome-wide association studies, eQTL analysis, and collaborations on large-scale biological datasets. Education: PhD in Chemistry, The Scripps Research Institute, 2002 B.A. in Chemistry, Computing and Information Systems, Integrated Science, Northwestern University, 1998 Research Interests: Computational biology, drug repurposing, bioinformatics tool development, cancer genomics, immunology, and open science initiatives. His work bridges computer science and biology to create tools that accelerate biomedical research and democratize data access. Collaborations & Impact: Su collaborates globally on projects ranging from spatial transcriptomics to SARS-CoV-2 drug discovery. His lab's contributions include the ReFRAME drug repurposing library and frameworks for genomic variant interpretation (e.g., CIViC, CAGI). These efforts highlight his commitment to translational research and open data principles. Lab & Team: The lab employs graduate students, postdocs, and bioinformatics experts. Projects emphasize open-source tool development, large-scale data analysis, and interdisciplinary collaborations. The team's work is showcased through platforms like Outbreak.info and the EXRNA Atlas.

Chunlei WuView profile

Professor

• Biomedical Data Integration
• Semantic Knowledge Representation
• Cloud Computing in Biomedicine
• +4 more

Chunlei Wu is a Professor at The Scripps Research Institute in the Department of Integrative Structural and Computational Biology. He leads a team developing large-scale biomedical data integration systems and tools, focusing on applying data science and cloud computing to advance biomedical discovery. His work emphasizes semantic knowledge representation, API-driven resource discovery, and open science infrastructure. Affiliations: Scripps Research Institute (2021–Present: Tenured Professor; 2017–2021: Associate Professor) Education: PhD in Biomathematics/Biostatistics (2006, UT Health Science Center Houston), B.S./M.S. in Biochemistry (1997/2000, Nanjing University) Research Interests: Wu’s lab creates foundational tools like MyGene.info, MyVariant.info, and BioThings SDK, which serve as scalable APIs for querying gene, variant, and chemical data. These platforms support drug discovery, genomic analysis, and pandemic response (e.g., Outbreak.info for SARS-CoV-2 surveillance). His work bridges data interoperability challenges through semantic integration and FAIR principles. Awards: Recognized for contributions to biomedical informatics, including the 2017 ESWC Best In-Use Paper Award and hackathon victories for API development. His tools are widely adopted, with MyGene.info processing ~30M monthly API requests. Labs/Teams: A multidisciplinary team includes senior scientists (e.g., Ginger Tsueng), programmers, and developers focused on API engineering, bioinformatics pipelines, and community engagement.

Karol PrudilView profile

Lecturer

• Graphic Design
• Typography
• Book Design
• +3 more

Karol Prudil is a Slovak graphic designer and typographer serving as a Lecturer in the Department of Visual Communication at the Academy of Fine Arts and Design in Bratislava. His professional practice spans publication design, packaging design, typeface creation, and visual identity development, balancing academic responsibilities with an extensive portfolio of commissioned work for publishers, cultural institutions, and commercial clients across Europe. Prudil's educational foundation includes: Master of Fine Arts from Academy of Fine Arts in Bratislava, Department of Visual Communication (2003-2009) under Doc. Pavel Choma Academy of Arts, Architecture and Design in Prague – Font and Typography studio (2008) with František Štorm SOU Polygraphics in Bratislava diploma (1997-2001) His creative research explores materiality in typography, innovative book structures, and the relationship between form and function in visual communication. Prudil has developed several notable typefaces including Klin and its variants, recognized for blending geometric precision with organic, tactile characteristics. His design philosophy emphasizes thoughtful material choices, structural innovation, and creating meaningful user experiences through interactive elements in books and packaging. The recurring themes in his portfolio include spatial relationships in two-dimensional design, material experimentation, and systems that invite user participation across physical and digital media. Analysis of Prudil's publication history reveals consistent exploration of book form boundaries and sophisticated understanding of typography across media. His work bridges historical design traditions with contemporary needs, resulting in conceptually rich yet functionally elegant solutions. The evolution from his early award-winning lie-stand book (2007) to current remini notebook brand demonstrates maturation from experimental forms to sustainable commercial applications while maintaining design integrity. Prudil's professional recognition includes: National Design Award 2009 – Klin Font recognition National Design Award 2007 – interactive book lie-stand recognition As an educator, Prudil conducts workshops on book binding and paper work since 2011, alongside lectures on books, paper, and business development. His teaching emphasizes hands-on material experience while developing conceptual depth. His professional practice operates through the registered brand 'remini' (established 2012), focusing on notebooks and diaries, and through collaborations with publishing houses and cultural institutions including participation in international projects like the SIDEWAYS exhibition at the Venice Architecture Biennale.

• Stochastic PDEs
• Regularity structures
• Coarse paths
• +5 more

Mate Gerencser is an Associate Professor at Vienna University of Technology (TU Wien) within the Institute for Analysis and Scientific Computing (E 101). Since March 2024, he has been supported by an ERC Starting Grant. His research focuses on stochastic partial differential equations (SPDEs), regularization by noise, regularity structures, and numerical methods for stochastic equations. He leads projects such as the ERC StG Project on 'Stochastic PDEs and Renormalization' and the FWF START Project. His research interests span stochastic PDEs, including their theoretical foundations and numerical approximations. Key areas include the analysis of rough paths, KPZ-type equations, and the interplay between noise and equation regularity. Recent work emphasizes high-order approximation schemes and boundary renormalization techniques. Gerencser has received prestigious grants, including the ERC Starting Grant (2024), and has contributed to leading journals in probability and stochastic analysis. He teaches courses such as 'Stochastic PDEs' and 'Applied Mathematics Foundations' at TU Wien. His research group actively collaborates on projects addressing stochastic dynamics in continuous and discrete systems, with a focus on theoretical rigor and computational methods.

• Neuromuscular Medicine
• Duchenne Muscular Dystrophy
• Becker Muscular Dystrophy
• +7 more

Peter I Karachunski is an Associate Professor in the Department of Neurology at the University of Minnesota, Medical School. His clinical and research work is centered on neuromuscular disorders, with a strong focus on muscular dystrophies and inherited neuromuscular diseases. Position: Associate Professor Department: Neurology Institution: University of Minnesota Email: karac001@umn.edu His research interests include Duchenne and Becker muscular dystrophies, spinal muscular atrophy (SMA), Pompe disease, and neuromuscular biopsy techniques. He is actively involved in advancing the genetic and clinical understanding of these disorders, particularly in pediatric populations. His work emphasizes diagnostic precision, biomarker development, and therapeutic evaluation through clinical trials. The recent articles highlight a strong trend in clinical translation and diagnostic methodology. Much of the output is focused on practical clinical guidance, such as in the Clinical Handbook of Neuromuscular Medicine , and on genotype-phenotype correlations in rare diseases like Pompe disease. The research spans both clinical neurology and molecular genetics, indicating a multidisciplinary approach to neuromuscular disease. Dr. Karachunski is the Principal Investigator on multiple active research projects, including: Phase 2 study of EDG-5506 in Becker Muscular Dystrophy (Edge Therapeutics) Phase 1b study of ASP0367 in pediatric DMD (Astellas Pharma) Long-term SMA patient registry (Avexis, Inc) MDA MOVR Registry (Muscular Dystrophy Association) Phase 1 trial of myogenic progenitors for DMD (Duchenne UK, as Co-I) He frequently collaborates with Dr. Peter B. Kang and contributes to national and international efforts in neuromuscular disease research. He has also contributed to educational and standardization efforts, such as developing swallow study protocols for SMA treatment assessment. He is affiliated with the following labs and research teams: Neuromuscular Division, Department of Neurology, University of Minnesota Collaborator in the GRASP Consortium (for LGMD research) Member of multi-institutional clinical trial networks for DMD and SMA

John D. FryerView profile

Professor

• Neuroscience
• Alzheimer's Disease
• Neuroinflammation
• +10 more

John D. Fryer, Ph.D., is a Professor of Neuroscience and Consultant in MCA Neuroscience at Mayo Clinic in Phoenix, Arizona. His research focuses on the molecular mechanisms of Alzheimer's disease, particularly the roles of genetic risk factors such as CLU, TREM2, and APOE in neuroinflammation, amyloid and tau pathology, and cerebrovascular dysfunction. His research interests include: Pathogenesis of Alzheimer's disease Role of microglia and neuroinflammation Genetic risk factors in neurodegeneration Consequences of sepsis on cognitive decline Gut microbiome's influence on mood and cognition Fryer's lab employs mouse genetic models and in vitro systems to investigate how high-fat diet and exercise alter the gut microbiome and impact anxiety and cognition. His work bridges molecular neuroscience with translational implications for patient care. The recent articles from his lab demonstrate a strong focus on APOE4-related mechanisms, microglial function, cerebrovascular integrity, and TDP-43 pathology in ALS/FTD. These studies appear in leading journals such as Nature Immunology , Science , Neuron , and Nature Neuroscience , highlighting his contributions to understanding neuroimmune interactions and genetic drivers of neurodegeneration. Fryer has not been explicitly listed as receiving scientific awards in the provided text. He advises or collaborates with numerous researchers, though specific student names are not provided in the available information. His lab is actively involved in grant-funded research exploring fundamental mechanisms of brain diseases. His laboratory investigates the intersection of immune function, genetics, and neural health, with ongoing projects on the gut-brain axis and post-sepsis cognitive impairment.

Akhilesh PandeyView profile

Professor

• Proteomics
• Metabolomics
• Genomics
• +7 more

Akhilesh Pandey, MD, PhD, is a Professor of Laboratory Medicine and Pathology and Pharmacology at Mayo Clinic, leading the Systems Biology and Translational Medicine Laboratory and the Advanced Diagnostics Laboratory's mass spectrometry efforts. As Director of the Proteomics Core, he integrates multi-omics technologies (proteomics, metabolomics, genomics) to address biomedical challenges. His research focuses on cancer mechanisms (e.g., multiple myeloma), congenital disorders of glycosylation, and precision medicine through biomarker discovery and single-cell proteomics. Education: MD from Armed Forces Medical College, PhD in Molecular Biology from University of Michigan, postdoctoral training at MIT/Whitehead Institute and University of Michigan. Clinical residency at Brigham and Women's Hospital. Research Interests: Multi-omics technologies for disease diagnosis, glycobiology biomarkers, single-cell proteomics, and translational applications of proteomics. His lab pioneered the human proteome map (Nature, 2014). Publications & Impact: Over 500 peer-reviewed articles, emphasizing biomarker discovery and therapeutic targets. Recent work includes multi-analyte cancer signatures and venetoclax resistance mechanisms. Awards: Multiple international honors including HUPO's Proteomic Sciences Award and India's Margdarshi Award. He founded the Institute of Bioinformatics in India (2002). Labs & Teams: Systems Biology Lab and Proteomics Core at Mayo Clinic. Collaborates on projects like the Mayo Clinic Center for Clinical Proteomics (NCI-funded).

Marcin BiegasView profile

Assistant Professor

• Biblical Studies
• Intertestamental Literature
• Dead Sea Scrolls
• +7 more

Rev. Dr. Marcin Biegas is an Assistant Professor in the Department of Biblical Philology and Intertestamental Literature at the Faculty of Theology, John Paul II Catholic University of Lublin. His scholarly work focuses on the Dead Sea Scrolls, particularly the Great Psalms Scroll (11Q5), and the portrayal of King David in intertestamental literature. He is actively engaged in research, publication, academic service, and public outreach. John Paul II Catholic University of Lublin – Assistant Professor, Department of Biblical Philology and Intertestamental Literature, Faculty of Theology His research interests lie at the intersection of biblical exegesis, early Jewish writings, and Qumran studies. He investigates literary structures, theological themes, and textual variants in apocryphal and pseudepigraphal works, especially those concerning Davidic traditions and the Psalms. His work combines philological precision with theological insight. The recent publications and conference presentations of Dr. Biegas reveal a consistent focus on the figure of King David across Qumran texts, the structure of the Psalms Scroll (11Q5), and comparative analyses of apocryphal and canonical writings. His work spans textual criticism, literary analysis, and theological interpretation, primarily within Second Temple Judaism. He frequently contributes to Biblical Annals , participates in national and international conferences, and engages in collaborative research projects. Reviewer, Biblical Annals (2022–2024) Reviewer, Sandomierz Studies. Theology-Philosophy-History (2020) Member, Association of Polish Biblical Scholars (since 2021) Member, Association for the Support of Biblical Studies "Verbum Sacrum" Dr. Biegas has served as a scientific supervisor (promoter) for doctoral research on apocryphal Davidic texts from Qumran and is a contractor in a Ministry of Education and Science-funded project titled "From the Book of Enoch to the Fourth Sibylline: The Old Testament Apocrypha between Tradition and Innovation." He has organized and co-hosted national and international conferences on biblical themes and has delivered lectures on television and at academic institutions. His fieldwork includes research trips to Jerusalem and archaeological sites in Israel such as Tel Arad, Tel Beer Sheva, Shiloh, Samaria, Gerizim, and Tell Balata, supporting his textual research with historical and archaeological context. He has not established a named laboratory, but his work is deeply integrated into the academic and research infrastructure of the Faculty of Theology at KUL.

Sandra PohlView profile

Professor

• Lysosomal storage disorders
• Mucolipidosis type II and III
• Osteogenesis imperfecta
• +5 more

Prof. Dr. Sandra Pohl is a full Professor at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the Department of Osteology and Biomechanics. Her research focuses on lysosomal storage disorders, particularly mucolipidosis types II and III, and their systemic effects on bone, cartilage, kidney and the central nervous system. She employs mouse models, human genetic studies and translational approaches to dissect disease mechanisms and develop therapeutic strategies. Education & Training No specific educational details provided in the source material; only the academic title "Prof. Dr. (PhD)" is listed. Research Interests Prof. Pohl’s work centers on: Molecular pathology of mucolipidosis type II (I-cell disease) and type III (pseudo-Hurler polydystrophy). GlcNAc-1-phosphotransferase biology and its role in lysosomal enzyme targeting. Skeletal manifestations of lysosomal storage disorders, including osteopenia, cartilage degeneration and dysostosis multiplex. Neurocognitive outcomes and CNS imaging in mucolipidosis patients. Enzyme replacement therapy design and evaluation in pre-clinical mouse models. Proteostasis, autophagy and ubiquitin-proteasome system interactions in disease pathogenesis. Publication Trends Between 2020 and 2024, Prof. Pohl has published extensively on the intersection of lysosomal dysfunction and skeletal/renal/neurological pathology. Her recent articles emphasize: Genotype–phenotype correlations in GNPTAB/GNPTG variants. Translational mouse models recapitulating human mucolipidosis. Multi-omics profiling (proteomics, imaging, metabolomics) to uncover disease biomarkers. Interdisciplinary studies linking basic cell biology to clinical manifestations. Research Support & Collaborations Prof. Pohl currently leads or co-leads the following initiatives: SFB 877, Teilprojekt B03: “Proteolysis-ver” (exact title abbreviated in source) – a collaborative research center funded by the German Research Foundation (DFG). Cross-institutional consortia involving nephrologists, neurologists, geneticists and imaging specialists across Germany and internationally. Laboratory & Core Facilities Her team utilizes state-of-the-art core facilities provided by UKE, including: Transgenic mouse core Advanced imaging and microscopy Mass-spectrometry-based proteomics High-throughput sequencing and bioinformatics platforms

Dörte WittenburgView profile

Research Professor

• Statistical Genetics
• Quantitative Trait Loci (QTL) Analysis
• Genomic Selection
• +3 more

Dörte Wittenburg is a Research Professor at the Research Institute for Farm Animal Biology (FBN) , leading the Working Group Statistics in Genomics since 2019 and the Focus Topic Promoting Diversity in Animal Farming . She contributes to the Master Programme Sustainable Agricultural Systems at University Rostock and has authored 15+ articles on statistical genomics. Education : Habilitation (2021), PhD in Biomathematics (2008), Diploma in Business Mathematics (2005) Research Interests include: Statistical methods for genetic effects on quantitative traits Penalized regression with genomic dependencies Population-genetic parameter estimation (linkage disequilibrium, recombination rates) Article Trends focus on: Genomic selection and QTL analysis Machine learning in agricultural genetics Sex-specific and species-specific recombination mapping Admixture and family structure modeling Scientific Awards : DGFZ Preis 2020 (Masterarbeiten) for Estimation of genetic parameters of milk urea content Advising involves offering master theses in animal breeding at University Rostock. Grants include funding for projects like Improving genome-based phenotype prediction (2013-2018) and BovIBI Bovine Integrative Bioinformatics for Genomic Selection (2008-2012).

Ron D. JachimowiczView profile

Associate Professor

• DNA repair
• Genome stability
• Aging
• +4 more

Ron D. Jachimowicz is a Max Planck Research Group Leader specializing in DNA repair mechanisms and their relationship to aging and cancer development. As a Privatdozent (equivalent to Associate Professor), he leads an independent research group at the Max Planck Institute focused on understanding how DNA repair pathways impact genome stability, aging processes, and cancer progression. His work bridges basic science with clinical applications, particularly in lymphoma research. Dr. Jachimowicz's research centers on the critical relationship between DNA repair mechanisms and aging. His group investigates defects in DNA repair pathways in patients with genome instability syndromes and in patients suffering from mantle cell lymphoma, utilizing an interdisciplinary approach that combines biochemistry, cell biology, computational biology, and mouse genetics. Key research areas include the role of UBQLN4 in DNA repair pathway choice, ATM signaling in DNA damage response, and the connection between genome maintenance defects and age-related diseases. His work has revealed important mechanisms linking DNA repair deficiencies to cancer development, particularly in lymphomas, and has identified potential therapeutic targets for cancer treatment. Analysis of Dr. Jachimowicz's publication record shows a consistent focus on DNA repair mechanisms and their implications for cancer biology. His research demonstrates how defects in DNA repair pathways lead to genome instability, which drives both aging processes and cancer development. Recent publications highlight his work on UBQLN4's role in DNA repair pathway choice, ATM signaling in immune surveillance of lymphoma, and the development of targeted therapies for cancers with specific DNA repair deficiencies. His interdisciplinary approach combines molecular biology, mouse models, and clinical data to translate basic discoveries into potential therapeutic strategies. Scientific Awards: Theodor Frerichs Prize from the German Society for Internal Medicine (DGIM), 2020 Dr. Jachimowicz serves as principal investigator for multiple significant research grants and advises doctoral students in his laboratory. His research is supported by prestigious funding including the German Research Foundation (DFG) Research Unit FOR5504 (2023-2026), Collaborative Research Center SFB1530 (2022-2025), and the Research Network CANTAR from the Ministry of Culture and Science of North Rhine-Westphalia (2022-2026). He also serves as co-speaker for the Else Kröner Research College on Clonal Evolution in Cancer. His doctoral student Julia Hansen received a scholarship from the German Academic Scholarship Foundation in 2022. Dr. Jachimowicz leads a dynamic research laboratory focused on DNA repair mechanisms and their relationship to aging and cancer. His group employs a comprehensive interdisciplinary approach that integrates biochemical, cellular, computational, and genetic techniques to investigate how defects in DNA repair pathways contribute to genome instability syndromes and cancer development. The lab's work has particular relevance for understanding mantle cell lymphoma and developing targeted therapeutic interventions based on DNA repair deficiencies.

Laura ErmertView profile

Researcher

• Seismic Interferometry
• Ambient Noise Monitoring
• Computational Seismology
• +3 more

Dr. Laura Ermert is an Established Researcher at the Swiss Seismological Service (SED) of ETH Zurich. Her work focuses on computational seismology, ambient noise monitoring, and seismic interferometry. She holds a PhD from ETH Zurich (2013–2018) under Prof. Andreas Fichtner, followed by postdoctoral positions at the University of Washington, Harvard University, and the University of Oxford. Her research explores shallow structure monitoring, basin resonances, and the influence of ocean microseism sources on ambient noise cross-correlation amplitudes. She has contributed to projects like the DEEP initiative for geothermal reservoir modeling and collaborated on Mexico City basin subsidence studies funded by the Packard Fellowship. Dr. Ermert co-developed Python tools like noisi for ambient noise analysis and pioneered methods for ambient seismic source inversion. Her studies include modal analysis of Alpine valley resonances and global-scale ambient noise inversion. She actively promotes gender equity in seismology through collaborative initiatives.

• Protein Aggregation
• Amyloids
• Neurodegenerative Diseases
• +7 more

Benedetta Bolognesi is a Group Leader at the Institute for Bioengineering of Catalonia (IBEC), focusing on protein phase transitions in health and disease. She previously earned her PhD in Chemistry from the University of Cambridge (UK) under Prof. Chris Dobson, studying amyloid-beta aggregation in Alzheimer's disease. Her postdoctoral work at the Centre for Genomic Regulation (Barcelona, Spain) was supported by a Marie Curie Interdisciplinary Fellowship. Current Role: Group Leader, Protein Phase Transitions in Health and Disease Research Focus: Protein aggregation mechanisms, amyloid formation, deep mutational scanning (DMS), yeast models for neurodegenerative diseases Her research employs DMS to quantify mutation effects on disordered protein domains, particularly in amyloid-beta and prion-like proteins. She investigates liquid condensates and amyloids in neurodegenerative contexts like Alzheimer's and Fragile X syndrome. Recent publications demonstrate her leadership in amyloid nucleation studies using high-throughput methods and interpretable AI models. Collaborations include researchers like Ben Lehner and Mireia Seuma. Her work bridges bioengineering and molecular biology to decode protein aggregation rules. Bolognesi's lab at IBEC explores protein phase transitions through interdisciplinary approaches, integrating yeast systems and computational biology. Key contributions include atlases of variant effects and insights into amyloid transition states.

Anna WhitfieldView profile

Professor

• Plant-Virus-Vector Interactions
• Molecular Virology
• Functional Genomics
• +5 more

Anna Whitfield is a Professor in the Department of Entomology and Plant Pathology at North Carolina State University , where she joined in 2017 as part of the Chancellor’s Faculty Excellence Program in Emerging Plant Diseases and Global Food Security. Her research focuses on plant-virus-vector interactions , aiming to develop biologically-based strategies for sustainable disease control. Education : M.S. from the University of California-Davis; Ph.D. from the University of Wisconsin-Madison. Research Priorities : Molecular mechanisms of virus transmission, functional genomics of insect vectors, CRISPR/Cas9 genome editing for vector competence reduction, RNA interference for pest control, and plant rhabdovirus infectious clone development. Her work integrates CRISPR, RNAi, and LAMP/Cas12a diagnostic tools to combat resistance-breaking variants of Tomato Spotted Wilt Virus (TSWV) and Maize Mosaic Virus (MMV). She leads multiple USDA-funded grants targeting thrips and orthotospovirus control through innovative molecular approaches. Scientific Awards : Alumni Outstanding Research Award (2023) NSF Faculty Early Career Development (CAREER) Program (2010) American Society for Virology Joel M. Dalrymple Memorial Award (2003) Whitfield mentors a diverse group of Ph.D., M.S., and undergraduate researchers , with former lab members now in academia and the agricultural biotech industry. She also contributes to plant disease management programs via the Plant-Aid sensor platform for real-time pathogen detection.